Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA (Q80731905)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Meyer J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Rhein M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Schiedlmeier B

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kustikova O

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Rudolph C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kamino K

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Neumann T

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Yang M

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Wahlers A

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Reuther GW

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Schlegelberger B

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Ganser A

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Baum C

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Li Z

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

2 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

2171-2180

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17673903%20AND%20SRC:MED&resulttype=core&format=json

Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML.

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Genetics of myeloid malignancies: pathogenetic and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Oncogenic kinase signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Ras, PI(3)K and mTOR signalling controls tumour cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

The uniqueness of being a neurotrophin receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Neurotrophins mediate human embryonic stem cell survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Expression of neurotrophins and their receptors in human bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Expression of the nerve growth factor receptor c-TRK in human myeloid leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Murine leukemia induced by retroviral gene marking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Expression of the p75 neurotrophin receptor in acute leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Antileukemic activity of rapamycin in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Insertional mutagenesis by replication-deficient retroviral vectors encoding the large T oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Tumor cells escape suicide gene therapy by genetic and epigenetic instability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Bcl11b is required for differentiation and survival of αβ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

The BCL11 gene family: involvement of BCL11A in lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Neurotrophin signal transduction in the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Phosphatidic acid-mediated mitogenic activation of mTOR signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Expression and regulation of phospholipase D during neuronal differentiation of PC12 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Essential role for phospholipase D2 activation downstream of ERK MAP kinase in nerve growth factor-stimulated neurite outgrowth from PC12 cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Phospholipase D stimulation by receptor tyrosine kinases mediated by protein kinase C and a Ras/Ral signaling cascade.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Activation of Trk neurotrophin receptors in the absence of neurotrophins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

TrkA glycosylation regulates receptor localization and activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Implication of phospholipase D2 in oxidant-induced phosphoinositide 3-kinase signaling via Pyk2 activation in PC12 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021

Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404882

7 January 2021